Back to Search
Start Over
Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury.
- Source :
-
Frontiers in immunology [Front Immunol] 2021 Jun 24; Vol. 12, pp. 669162. Date of Electronic Publication: 2021 Jun 24 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Renal ischemia is the most common cause of acute kidney injury (AKI) that might be exacerbate lupus activity through neutrophil extracellular traps (NETs) and apoptosis. Here, the renal ischemia reperfusion injury (I/R) was performed in Fc gamma receptor 2b deficient (Fcgr2b-/-) lupus mice and the in vitro experiments. At 24 h post-renal I/R injury, NETs in peripheral blood neutrophils and in kidneys were detected using myeloperoxidase (MPO), neutrophil elastase (NE) and citrullinated histone H3 (CitH3), as well as kidney apoptosis (activating caspase-3), which were prominent in Fcgr2b-/- mice more compared to wild-type (WT). After 120 h renal-I/R injury, renal NETs (using MPO and NE) were non-detectable, whereas glomerular immunoglobulin (Ig) deposition and serum anti-dsDNA were increased in Fcgr2b-/- mice. These results imply that renal NETs at 24 h post-renal I/R exacerbated the lupus nephritis at 120 h post-renal I/R injury in Fcgr2b-/- lupus mice. Furthermore, a Syk inhibitor attenuated NETs, that activated by phorbol myristate acetate (PMA; a NETs activator) or lipopolysaccharide (LPS; a potent inflammatory stimulator), more prominently in Fcgr2b-/- neutrophils than the WT cells as determined by dsDNA, PAD4 and MPO. In addition, the inhibitors against Syk and PAD4 attenuated lupus characteristics (serum creatinine, proteinuria, and anti-dsDNA) in Fcgr2b-/- mice at 120 h post-renal I/R injury. In conclusion, renal I/R in Fcgr2b-/- mice induced lupus exacerbation at 120 h post-I/R injury partly because Syk-enhanced renal NETs led to apoptosis-induced anti-dsDNA, which was attenuated by a Syk inhibitor.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Saisorn, Saithong, Phuengmaung, Udompornpitak, Bhunyakarnjanarat, Visitchanakun, Chareonsappakit, Pisitkun, Chiewchengchol and Leelahavanichkul.)
- Subjects :
- Acute Kidney Injury drug therapy
Acute Kidney Injury immunology
Acute Kidney Injury pathology
Animals
Disease Models, Animal
Disease Progression
Female
Kidney drug effects
Kidney immunology
Kidney pathology
Lupus Nephritis drug therapy
Lupus Nephritis immunology
Lupus Nephritis pathology
Mice, Inbred C57BL
Mice, Knockout
Neutrophils drug effects
Neutrophils immunology
Neutrophils pathology
Phosphodiesterase 4 Inhibitors pharmacology
Protein Kinase Inhibitors pharmacology
Receptors, IgG genetics
Reperfusion Injury drug therapy
Reperfusion Injury immunology
Reperfusion Injury pathology
Syk Kinase antagonists & inhibitors
Syk Kinase metabolism
Time Factors
Mice
Acute Kidney Injury metabolism
Apoptosis drug effects
Extracellular Traps metabolism
Kidney metabolism
Lupus Nephritis metabolism
Neutrophils metabolism
Receptors, IgG deficiency
Reperfusion Injury metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 34248948
- Full Text :
- https://doi.org/10.3389/fimmu.2021.669162